Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE QUANTITATIVE EVALUATION OF SPASMOLYTIC DRUGS IN VITRO

LLOYD C. MILLER, T. J. BECKER and M. L. TAINTER
Journal of Pharmacology and Experimental Therapeutics March 1948, 92 (3) 260-268;
LLOYD C. MILLER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. J. BECKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. L. TAINTER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

An experimental procedure is described for using the Magnus-type excised organ preparation for comparison of the spasmolytic potency of compounds under test against standardized spasms induced by fixed doses of barium, histamine or acetylcholine. The proportion of preparations giving a positive response at different dose levels is changed to straight line functions by using probit and log-dose transformations. From these the ED50 and ratios of activity can be readily determined by conventional methods.

Use of the symbol pD is proposed to express the concentrations required for a standard effect. This value is the logarithm of the reciprocal of the concentration of the active drug or, expressed alternatively, the log of the degree of dilution. It thus is entirely comparable to the term pH, now widely accepted as a convenient means of expressing otherwise unwieldy numerical values of hydrogen ion concentration.

This general assay procedure may be readily adapted to quantitating the responses of any smooth muscled organ to tonic or depressant drugs by appropriate choice of the standard and test agents.

Footnotes

    • Received October 14, 1947.
  • 1948 by The American Society for Pharmacology and Experimental Therapeutics

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 92, Issue 3
1 Mar 1948
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE QUANTITATIVE EVALUATION OF SPASMOLYTIC DRUGS IN VITRO
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE QUANTITATIVE EVALUATION OF SPASMOLYTIC DRUGS IN VITRO

LLOYD C. MILLER, T. J. BECKER and M. L. TAINTER
Journal of Pharmacology and Experimental Therapeutics March 1, 1948, 92 (3) 260-268;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE QUANTITATIVE EVALUATION OF SPASMOLYTIC DRUGS IN VITRO

LLOYD C. MILLER, T. J. BECKER and M. L. TAINTER
Journal of Pharmacology and Experimental Therapeutics March 1, 1948, 92 (3) 260-268;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Powerful Activation of Skeletal Muscle Actomyosin ATPase by Goniodomin A Is Highly Sensitive to Troponin/Tropomyosin Complex
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics